Early phase clinical development is a critical stage in the process of bringing new drugs and therapies to market. It typically consists of Phase I and Phase II clinical trials, during which experimental treatments are tested in a small group of human volunteers for the first time. Phase I trials focus on safety and dosage, while Phase II trials assess efficacy and potential side effects.